Callidus Software Inc. (NASDAQ: CALD)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Callidus Software Inc. (“Callidus”) (NASDAQ: CALD) concerning the merger with SAP SE. Under the terms of the agreement, valued at approximately $2.4 billion, Callidus shareholders will only receive $36.00 per Callidus share held.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether the Board of Directors of Callidus is acting in the shareholders’ best interests, whether the board is properly negotiating a higher share price for the shareholders, and whether the board has employed an adequate process to review and act on the proposed transaction.

The Briscoe Law Firm, PLLC is a full-service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.

CSRA Inc. (NYSE: CSRA)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of CSRA Inc. (“CSRA”) (NYSE: CSRA) concerning the acquisition by General Dynamics. Under the terms of the agreement, CSRA shareholders will only receive $40.75 per CSRA share owned. The consideration is significantly lower than at least one analyst’s estimated value of $42.00.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether CSRA’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of CSRA could be as high as $42.00 per share.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.

Advance Auto Parts, Inc. (NYSE: AAP)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, has launched an investigation of Advance Auto Parts, Inc. (“Advance Auto”) (NYSE: AAP) and several officers and directors for possible violations of federal securities laws.

The firm is investigating potential legal claims against the officers and Board of Directors of Advance Auto. If you are an affected Advance Auto shareholder and want to learn more about the investigation, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, or call toll free at (888) 809-2750. There is no cost or fee to you.

The firm seeks to determine if the defendants violated certain provisions of the Securities Exchange Act of 1934. On May 24, 2017, Advance Auto reported financial and operating results for the first fiscal quarter of 2017, including a quarterly sales decrease of 3.0%. Advance Auto also reported a quarterly decrease in gross profit, “primarily driven by investments in the customer, inventory optimization efforts and supply chain expense deleverage due to the comparable store sales decline.” Further, Advance Auto reported that its quarterly comparable store sales had declined 2.7%. Then, on August 15, 2017, Advance Auto reported its financial and operational results for the second quarter of 2017, disclosing to investors that “comparable store sales for the quarter were flat.” Further, and with respect to full-year fiscal 2017 financial and operational guidance, the Company: (i) decreased its comparable store sales guidance from 0–2% growth to 3–1% decline; (ii) decreased its adjusted operating income rate guidance from a 15–35 basis point year-over-year improvement to a 200–300 basis point year-over-year reduction; (iii) decreased its free cash flow guidance by $100 million; and (iv) increased its “integration and transformation” guidance from approximately $30–35 million to approximately $100–150 million. Following each announcement, Advance Auto’s stock price dropped.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Dr Pepper Snapple Group, Inc. (NYSE: DPS)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Dr Pepper Snapple Group, Inc. (“Dr Pepper”) (NYSE: DPS) concerning the sale to Keurig Green Mountain, Inc. Under the terms of the agreement, Dr Pepper shareholders will only receive $103.75 for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $130.00 per share.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Dr Pepper’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of the stock could be as high as $130.00.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Juno Therapeutics, Inc. (NASDAQ: JUNO)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Juno Therapeutics, Inc. (“Juno”) (NASDAQ: JUNO) concerning the acquisition by Celgene Corporation. Under the terms of the agreement, Juno shareholders will only receive $87.00 per Juno share owned. The consideration is significantly lower than at least one analyst’s estimated value of $98.00.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Juno’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of Juno could be as high as $98.00 per share.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.

Blackhawk Network Holdings, Inc. (NASDAQ: HAWK)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Blackhawk Network Holdings, Inc. (“Blackhawk”) (NASDAQ: HAWK) concerning the acquisition by Silver Lake and P2 Capital Partners. Under the terms of the agreement, valued at approximately $3.5 billion, Blackhawk shareholders will only receive $45.25 in cash per Blackhawk share owned. The consideration is significantly lower than at least one analyst’s estimated value of $51.00.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Blackhawk’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of Blackhawk could be as high as $51.00 per share.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.

DST Systems, Inc. (NYSE: DST)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of DST Systems, Inc. (“DST”) (NYSE: DST) concerning the merger with SS&C Technologies Holdings, Inc. Under the terms of the agreement, valued at approximately $5.4 billion, DST shareholders will only receive $84.00 per DST share held.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether DST’s Board of Directors is acting in the shareholders’ best interests, whether the board is properly negotiating a higher share price for the shareholders, and whether the board has employed an adequate process to review and act on the proposed transaction.

The Briscoe Law Firm, PLLC is a full-service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, has launched an investigation of Ekso Bionics Holdings, Inc. (“Ekso”) (NASDAQ: EKSO) and several officers and directors for possible violations of federal securities laws.

The firm is investigating potential legal claims against the officers and Board of Directors of Ekso. If you are an affected Ekso shareholder and want to learn more about the investigation, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, or call toll free at (888) 809-2750. There is no cost or fee to you.

The firm seeks to determine if the defendants violated certain provisions of the Securities Exchange Act of 1934. Specifically, the investigation relates to Ekso’s announcement on December 14, 2017, advising investors that its internal control over financial reporting as of December 31, 2016 should no longer be relied upon and that a material weakness in its internal control over financial reporting existed as of such date. Then on December 27, 2017, Ekso filed an amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017. On this news, Ekso’s share price declined.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Eagle Bancorp, Inc. (NASDAQ: EGBN)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, has launched an investigation of Eagle Bancorp, Inc. (“Eagle”) (NASDAQ: EGBN) and several officers and directors for possible violations of federal securities laws.

The firm is investigating potential legal claims against the officers and Board of Directors of Eagle. If you are an affected Eagle shareholder and want to learn more about the investigation, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, or call toll free at (888) 809-2750. There is no cost or fee to you.

The firm seeks to determine if the defendants violated certain provisions of the Securities Exchange Act of 1934. Specifically, the investigation relates a December 1, 2017, report by Aurelius Value, which stated that it had uncovered evidence of an insider loan scheme involving Eagle’s Chairman and Chief Executive Officer, Ronald D. Paul, and certain of Eagle’s other Board members. The report stated, in relevant part, that insiders treat Eagle as “their own private piggy bank” and enrich themselves by carving out undisclosed special deals in which members of the management personally benefit from customer relationships. On this news, Eagle’s share price fell 24.49%.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP) concerning the sale to Mallinckrodt plc. Under the terms of the agreement, Sucampo shareholders will only receive $18.00 in cash for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $43.00 per share.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Sucampo’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of the stock could be as high as $43.00.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.